LabGenius integrates human and machine intelligence to facilitate the discovery of therapeutic antibodies. Their technology platform aims to improve the drug discovery process.
ML-driven antibody discovery
Robotic automation for antibody design
Therapeutic antibodies for cancer and inflammatory diseases
William Harvey Research Limited is a contract research organisation established in 1990, specialising in preclinical drug evaluation services for the Biotech and Pharmaceutical sectors.
AviadoBio is a biopharmaceutical development company focused on translating groundbreaking science into potentially life-changing medicines for patients with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).
ViroCell Biologics is an innovation-driven CDMO focused exclusively on the design and GMP manufacture of lentiviral and gamma-retro viral vectors to enable novel cell and gene therapies to enter clinical trials.
OncoCDx is a not-for-profit socially responsible research organisation established by researchers from top institutes and universities worldwide.
Company Details
LabGenius is operated by Labgenius Limited and is a Active company incorporated on 17 August 2012 with the registered office located in London, Greater London. Labgenius Limited was registered 13 years ago.